Based on the recent earnings call, the company has shown significant improvements in its financial performance. The Corporate segment expense decreased by 12% year over year, primarily due to productivity initiatives and merger synergies. Overall first quarter revenues were up slightly at $7.1 billion, with organic sales up 1%. The company also delivered double-digit segment EBIT growth and EBIT margins of 10.7%, which exceeded expectations. Additionally, the company's effective tax rate improved to 15% compared to last year, and diluted EPS increased to $0.53 from $0.48 a year ago.

The company also remains focused on delivering $2.1 billion in adjusted free cash flow for the year, with net debt to cap at 33.6% versus 39.7% at year-end. The company has also commenced a share repurchase program and expects to buy back about $200 million to $250 million of its shares during the rest of fiscal 2017.

Looking ahead to the second quarter, the company expects organic sales to be up 2% and EPS at $0.48 to $0.50, which is up 7% to 11% year over year. The company remains confident in delivering a strong fiscal 2017 and has reaffirmed its full-year guidance of $2.60 to $2.75, representing a year-over-year increase of 13% to 19%.

Overall, based on the company's recent financial performance and outlook, a compelling recommendation for an 'overweight' investment stance can be made. The company has shown strong growth in its revenues, EBIT margins, and diluted EPS, and is focused on delivering strong financial results for the year. With a solid start to fiscal 2017 and a reaffirmed full-year guidance, the company presents an attractive investment opportunity for investors seeking above-average returns.